Information  X 
Enter a valid email address

Duke Royalty Limited (DUKE)


Thursday 25 November, 2021

Duke Royalty Limited

Notice of Interim Results

RNS Number : 5124T
Duke Royalty Limited
25 November 2021

25 November 2021


Duke Royalty Limited


("Duke Royalty" or "Duke")


Notice of Interim Results

Duke Royalty, a provider of alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad, will announce its Interim Results for the six months ended 30 September 2021 ("Interim 2022") on Friday 3 December 2021.




For further information, please visit   or contact:



Duke Royalty Limited

Neil Johnson / Charlie Cannon Brookes / Hugo Evans


+44 (0) 1481 730 613

Cenkos Securities plc 

(Nominated Adviser

and Joint Broker)

Stephen Keys / Callum Davidson / Julian Morse / Michael Johnson

+44 (0) 207 397 8900




Canaccord Genuity

(Joint Broker)


Adam James / Georgina McCooke

+44 (0) 207 523 8000

SEC Newgate (PR)

Elisabeth Cowell/ Richard Bicknell/ Megan Kovach

 +44 (0) 20 3757 6880 [email protected]

About Duke Royalty 


Duke Royalty Limited provides alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad. Duke Royalty's experienced team provide financing solutions to private companies that are in need of capital but whose owners wish to maintain equity control of their business. Duke Royalty's royalty investments are intended to provide robust, stable, long term returns to its shareholders. Duke Royalty is listed on the AIM market under the ticker DUKE and is headquartered in Guernsey.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t